Journal of Pharmaceutical Investigation
Overview
Journal of Pharmaceutical Investigation is a scientific journal, published by Springer since 2010 in English. The journal's country of origin is Netherlands and its primary focus area is chemistry.
Details
Details
Abbr.
J Pharm Investig
Publisher
Springer
Start
2010
End
Continuing
Frequency
Bimonthly
p-ISSN
2093-5552
e-ISSN
2093-6214
Country
Netherlands
Language
English
Specialty
Chemistry
Metrics
Metrics
h-index / Ranks: 8879
39
SJR / Ranks: 5121
816
CiteScore / Ranks: 1018
11.70
Recent Articles
1.
Emami F, Keihan Shokooh M, Mostafavi Yazdi S
J Pharm Investig
. 2022 Dec;
53(1):35-57.
PMID: 36568503
Background: Most biopharmaceuticals are developed in liquid dosage forms that are less stable than solid forms. To ensure the stability of biopharmaceuticals, it is critical to use an effective drying...
2.
Thapa R, Kim J
J Pharm Investig
. 2022 Dec;
53(1):19-33.
PMID: 36568502
Background: In recent decades, there has been a considerable increase in the number of nanomedicine-based formulations, and their advantages, including controlled/targeted drug delivery with increased efficacy and reduced toxicity, make...
3.
Lee J, Kim J, Kang J, Lee H
J Pharm Investig
. 2022 Nov;
53(2):191-212.
PMID: 36320434
Background: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in acute respiratory distress, fatal systemic manifestations (extrapulmonary as well as pulmonary), and...
4.
Mohanto N, Park Y, Jee J
J Pharm Investig
. 2022 Aug;
53(1):153-190.
PMID: 35935469
Background: Several circumstances such as accidents, surgery, traumatic hemorrhagic shock, and other causalities cause major blood loss. Allogenic blood transfusion can be resuscitative for such conditions; however, it has numerous...
5.
Jeong S, Jang J, Lee Y
J Pharm Investig
. 2022 Aug;
53(1):119-152.
PMID: 35910081
Background: Cranial nerve-related diseases such as brain tumors, Alzheimer's disease, and epilepsy are serious diseases that continue to threaten human. Brain-related diseases are increasing worldwide, including in the United States...
6.
Shinn J, Kwon N, Lee S, Lee Y
J Pharm Investig
. 2022 May;
52(4):427-441.
PMID: 35573320
Background: Currently nanomedicines are the focus of attention from researchers and clinicians because of the successes of lipid-nanoparticles-based COVID-19 vaccines. Nanoparticles improve existing treatments by providing a number of advantages...
7.
Karmacharya P, Rudragouda Patil B, Kim J
J Pharm Investig
. 2022 Apr;
52(4):415-426.
PMID: 35369363
Background: Cancer remains a serious health concern worldwide, and different approaches are being developed for its treatment. The strategy to use the immune system as an approach for treating cancer...
8.
Vo D, Nguyen T, Maeng H
J Pharm Investig
. 2022 Mar;
52(3):341-351.
PMID: 35291466
Purpose: This study aimed to investigate the effects of 1α,25-dihydroxyvitamin D (1,25(OH)D) on the expression levels of organic cation/carnitine transporter 1 (OCTN1) as well as the pharmacokinetics and biodistribution of...
9.
Shim G, Jeong S, Oh J, Kang Y
J Pharm Investig
. 2022 Jan;
52(2):151-160.
PMID: 35013696
Background: Numerous drug delivery strategies have been studied, but many hurdles exist in drug delivery rates to the target site. Recently, researchers have attempted to remotely control the in vivo...
10.
Noh I, Lee K, Rhee Y
J Pharm Investig
. 2022 Jan;
52(3):273-292.
PMID: 35003824
Background: Nucleic acid-based gene therapy is a promising technology that has been used in various applications such as novel vaccination platforms for infectious/cancer diseases and cellular reprogramming because of its...